Article Information
History
- May 9, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Yvonne M. Mueller1,
- Thijs J. Schrama1,
- Rik Ruijten1,
- Marco W.J. Schreurs1,
- Dwin G.B. Grashof1,
- Harmen J. G. van de Werken1,2,
- Daniel Alvarez de la Sierra4,
- Caoimhe H. Kiernan1,
- Melisa D. Castro Eiro1,
- Marjan van Meurs1,
- Inge Brouwers-Haspels1,
- Manzhi Zhao1,
- Ling Li1,
- Harm de Wit1,
- Christos A. Ouzounis5,6,
- Merel E. P. Wilmsen1,
- Tessa Alofs1,
- Danique A. Laport1,
- Tamara van Wees1,
- Geoffrey Kraker7,
- Maria C. Jaimes7,
- Sebastiaan Van Bockstael7,
- Manuel Hernández-González4,
- Casper Rokx3,
- Bart J.A. Rijnders3,
- Ricardo Pujol-Borrell4 and
- Peter D. Katsikis1,*
- 1Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands
- 2Cancer Computational Biology Center, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands
- 3Department of Internal Medicine, Section Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands
- 4Immunology Division, Universitat Autònoma de Barcelona, Vall d’Hebron University Hospital, Barcelona, Spain
- 5School of Informatics, Faculty of Sciences, Aristotle University of Thessaloniki, Thessalonica, Greece
- 6Chemical Process & Energy Resources Institute, Centre for Research & Technology Hellas, Thermi, Thessalonica, Greece
- 7Cytek Biosciences, Fremont, CA, United States
- ↵*Address correspondence to Peter D. Katsikis (p.katsikis{at}erasmusmc.nl)
Posted May 09, 2021.
Immunophenotyping and machine learning identify distinct immunotypes that predict COVID-19 clinical severity
